Loews Trimmed Cvs Health (CVS) Holding By $1.62 Million; Brightcove (BCOV) Has 0.92 Sentiment

January 1, 2018 - By Darrin Black

Brightcove Inc. provides cloud-based services for video. The company has market cap of $245.89 million. The firm primarily offers Video Cloud, an online video platform that enables its clients to publish and distribute video to Internet-connected devices. It currently has negative earnings. The Company’s Video Cloud platform offers various features and functionalities, such as uploading and encoding, content management, video player technology, multi-platform video experiences, live video streaming, distribution and syndication, social media, advertising and monetization, and analytics.

Loews Corp decreased Cvs Health Corp (CVS) stake by 8% reported in 2017Q3 SEC filing. Loews Corp sold 20,000 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Loews Corp holds 230,000 shares with $18.70 million value, down from 250,000 last quarter. Cvs Health Corp now has $73.45B valuation. The stock decreased 0.75% or $0.55 during the last trading session, reaching $72.5. About 4.76 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 1, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Litespeed Management L.L.C. holds 6.04% of its portfolio in Brightcove Inc. for 1.19 million shares. Cooper Creek Partners Management Llc owns 1.26 million shares or 5.4% of their US portfolio. Moreover, Hawk Ridge Capital Management Lp has 3.08% invested in the company for 1.14 million shares. The Connecticut-based Mcclain Value Management Llc has invested 3.06% in the stock. Horrell Capital Management Inc., a Arkansas-based fund reported 385,000 shares.

Analysts await Brightcove Inc. (NASDAQ:BCOV) to report earnings on February, 15. They expect $-0.09 earnings per share, down 12.50% or $0.01 from last year’s $-0.08 per share. After $-0.11 actual earnings per share reported by Brightcove Inc. for the previous quarter, Wall Street now forecasts -18.18% EPS growth.

The stock increased 1.43% or $0.1 during the last trading session, reaching $7.1. About 150,409 shares traded. Brightcove Inc. (BCOV) has declined 2.44% since January 1, 2017 and is downtrending. It has underperformed by 19.14% the S&P500.

Since August 16, 2017, it had 0 insider purchases, and 7 sales for $58.32 million activity. $1.67 million worth of CVS Health Corporation (NYSE:CVS) was sold by Moriarty Thomas M. 39,340 shares were sold by Foulkes Helena, worth $3.22 million on Friday, September 15. $199,050 worth of stock was sold by SWIFT RICHARD J on Wednesday, August 16. Shares for $7.13 million were sold by Roberts Jonathan C. Shares for $18.88 million were sold by Denton David M on Monday, September 11. Shares for $20.03 million were sold by MERLO LARRY J on Wednesday, August 23.

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 59 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Friday, November 3. Oppenheimer maintained it with “Outperform” rating and $117 target in Thursday, December 17 report. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Monday, December 4 by RBC Capital Markets. Tigress Financial maintained CVS Health Corporation (NYSE:CVS) on Tuesday, December 26 with “Buy” rating. The rating was maintained by Oppenheimer with “Outperform” on Monday, November 2. As per Monday, February 6, the company rating was downgraded by Atlantic Securities. Needham maintained the shares of CVS in report on Friday, September 8 with “Hold” rating. Robert W. Baird downgraded CVS Health Corporation (NYSE:CVS) on Thursday, February 2 to “Neutral” rating. The rating was downgraded by Jefferies on Monday, December 12 to “Hold”. Deutsche Bank maintained the stock with “Hold” rating in Thursday, August 20 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: